Zhang Shu, Wang Guozheng, Fernig David G, Rudland Philip S, Webb Stephen E D, Barraclough Roger, Martin-Fernandez Marisa
Cancer and Polio Research Fund Laboratories, School of Biological Sciences, University of Liverpool, Liverpool, L69 7ZB, UK.
Eur Biophys J. 2005 Feb;34(1):19-27. doi: 10.1007/s00249-004-0428-x. Epub 2004 Aug 3.
Elevated levels of the calcium-binding regulatory protein, S100A4, have been shown to be causative of a metastatic phenotype in models of cancer metastasis and to be associated with reduced patient survival in breast cancer patients. Recombinant S100A4 protein interacts in vitro in a calcium-dependent manner with the heavy chain of non-muscle myosin isoform A at a protein kinase C phosphorylation site. At present, the mechanism of metastasis induction by S100A4 in vivo is almost completely unknown. The binding of S100A4 to a C-terminal recombinant fragment of non-muscle myosin heavy chain in living HeLa cells has now been shown using confocal microscopy, fluorescence lifetime imaging microscopy and time-correlated single-photon counting. The association between S100A4 and non-muscle myosin heavy chain was studied by determining fluorescence resonance energy transfer-derived changes in the fluorescence lifetime of enhanced cyan fluorescent protein fused to S100A4 in the presence of a recombinant fragment of the C-terminal region of non-muscle myosin heavy chain (rNMMHCIIA) fused to enhanced yellow fluorescent protein. There was no interaction between the non-muscle myosin heavy chain fragment and a calcium-binding-deficient mutant of S100A4 protein which has been shown to be defective in the induction of metastasis in model systems in vivo. The results demonstrate, for the first time, not only direct interaction between S100A4 and a target rNMMHCIIA in live mammalian cells, but also that the interaction between S100A4 and the non-muscle myosin heavy chain in vivo could contribute to the mechanism of metastasis induction by a high level of S100A4 protein.
钙结合调节蛋白S100A4水平升高已被证明在癌症转移模型中会导致转移表型,并与乳腺癌患者生存率降低有关。重组S100A4蛋白在体外以钙依赖的方式在蛋白激酶C磷酸化位点与非肌肉肌球蛋白同工型A的重链相互作用。目前,S100A4在体内诱导转移的机制几乎完全未知。现在已使用共聚焦显微镜、荧光寿命成像显微镜和时间相关单光子计数法证明了S100A4与活HeLa细胞中非肌肉肌球蛋白重链的C端重组片段的结合。通过在融合增强型黄色荧光蛋白的非肌肉肌球蛋白重链(rNMMHCIIA)C端区域重组片段存在的情况下,测定融合到S100A4的增强型青色荧光蛋白荧光寿命中荧光共振能量转移衍生的变化,研究了S100A4与非肌肉肌球蛋白重链之间的关联。非肌肉肌球蛋白重链片段与S100A4蛋白的钙结合缺陷突变体之间没有相互作用,该突变体在体内模型系统中已被证明在转移诱导方面存在缺陷。结果首次证明,不仅S100A4与活哺乳动物细胞中的靶标rNMMHCIIA之间存在直接相互作用,而且S100A4与非肌肉肌球蛋白重链在体内的相互作用可能有助于高水平S100A4蛋白诱导转移的机制。